TrialEuropean journal of clinical pharmacology2019

Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes.

Anne Gardin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.